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Enterohemorrhagic Escherichia coli (EHEC) is an extracellular path-
ogen that causes hemorrhagic colitis and hemolytic uremic syn-
drome. The proinflammatory cytokine, interleukin-1β, has been
linked to hemolytic uremic syndrome. Here we identify the nucle-
otide-binding domain and leucine rich repeat containing family,
pyrin domain containing 3 (NLRP3) inflammasome as an essential
mediator of EHEC-induced IL-1β. Whereas EHEC-specific virulence
factors were dispensable for NLRP3 activation, bacterial nucleic
acids such as RNA:DNA hybrids and RNA gained cytosolic access
and mediated inflammasome-dependent responses. Consistent
with a direct role for RNA:DNA hybrids in inflammasome activa-
tion, delivery of synthetic EHEC RNA:DNA hybrids into the cy-
tosol triggered NLRP3-dependent responses, and introduction of
RNase H, which degrades such hybrids, into infected cells specifi-
cally inhibited inflammasome activation. Notably, an E. coli rnhA
mutant, which is incapable of producing RNase H and thus harbors
increased levels of RNA:DNA hybrid, induced elevated levels of
NLRP3-dependent caspase-1 activation and IL-1β maturation. Col-
lectively, these findings identify RNA:DNA hybrids of bacterial or-
igin as a unique microbial trigger of the NLRP3 inflammasome.
Enterohemorrhagic Escherichia coli (EHEC) is an importantextracellular pathogen that causes diarrheal illness. EHEC
colonizes the surface of colonic epithelial cells using a type III
secretion system (T3SS) to inject dozens of bacterial effectors into
cells to modulate a variety of signaling pathways (1). In addition,
EHEC harbors virulence factors such as shiga toxin (Stx) and
a pO157 plasmid-encoded enterohemolysin, both implicated in
severe manifestations of EHEC disease such as hemorrhagic colitis
and hemolytic uremic syndrome (HUS), the life-threatening triad
of hemolytic anemia, thrombocytopenia, and renal failure (1).
Along with Stx, inflammation is thought to contribute to both
hemorrhagic colitis and HUS in EHEC infection (2). Coadmini-
stration of LPS greatly potentiates the action of Stx in a murine
HUSmodel, indicating that innate immune activation during EHEC
infection may play an important role in the development of systemic
disease (3). In addition, elevated serum levels of the proinflamma-
tory cytokine IL-1β have been observed in human EHEC infection
and are a major risk factor for HUS development (4).
The enormous proinflammatory potential of IL-1β is coun-
tered by critical regulatory checkpoints that control its production
in immune cells. In contrast to the majority of proinflammatory
cytokines, IL-1β is regulated at both the transcriptional and
posttranslational levels. It is synthesized as an inactive proform
following engagement of receptors such as Toll-like receptors (5)
and then processed by a cysteine protease, caspase-1 (IL-1β con-
verting enzyme; ICE). Enzymatically active caspase-1 is itself
converted from the inactive procaspase-1 form by the inflam-
masome complex (5). Such complexes consist of a cytosolic sensor
[which can be either a nucleotide-binding domain and leucine-
rich repeat containing (NLR) protein or AIM2], the adaptor
apoptosis-associated speck-like protein containing CARD (ASC)
and the effector molecule procaspase-1. In addition to IL-1β,
active caspase-1 also regulates IL-18 maturation and a form of
inflammatory cell death referred to as pyroptosis (6). During in-
fection, microbial products engage the activation of one or more
NLR and/or AIM2 inflammasomes to coordinate IL-1β pro-
duction. Nucleotide-binding domain and leucine rich repeat
containing family, pyrin domain containing 3 (NLRP3), the best-
studied inflammasome, plays a key role in host defense and is
activated by numerous bacterial, viral, and fungal pathogens, as
well as products associated with noninfectious inflammatory
diseases, such as uric acid and silica crystals (6). Recently,
bacterial mRNA was identified as a viability-associated patho-
gen-associated molecular pattern (vita-PAMP) important in pro-
moting the assembly of the NLRP3 inflammasome (7, 8).
Despite the importance of IL-1 production in the serious
manifestations of EHEC infection, the microbial element(s) that
triggers inflammasome activation has not been identified. In this
study, we found that EHEC triggers NLRP3 inflammasome acti-
vation. Bacterial factors that have been previously implicated in
inflammatory responses, such as an EHEC pore-forming toxin
or its T3SS, were dispensable for EHEC-induced inflammasome
activation. Rather, bacterial nucleic acids, such as RNA:DNA
hybrids and RNA, are the triggers of NLRP3 activation in EHEC
infection. Following phagocytosis, RNA:DNA hybrids of bacterial
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origin were observed as discrete foci and colocalized with cytosolic
inflammasome complexes containing NLRP3, ASC, and caspase-
1. Collectively, these studies identify bacterial RNA:DNA hybrids
as a unique class of microbe-associated molecular pattern with
innate immune stimulatory activity during microbial infection.
Results
EHEC Activates the NLRP3 Inflammasome Independent of Its Major
Virulence Factors. To identify host determinants required for the
proteolytic maturation of IL-1β in response to EHEC, we infected
bone marrow-derived macrophages (BMDMs) and dendritic cells
(BMDCs) from wild-type mice or mice deficient in various in-
flammasome components with EHEC. EHEC-induced IL-1β pro-
duction was abrogated in ASC-, caspase-1-, and NLRP3-deficient
macrophages and dendritic cells (Fig. 1 A–C and Fig. S1A).
Among the upstream cellular events involved in NLRP3 activa-
tion, Ca2+mobilization was not required for EHEC-induced IL-1β
production whereas reactive oxygen species production and K+
efflux were found to be required (Fig. S1 B–D). In contrast to
NLRP3, the NLRC4/IPAF inflammasome, which senses T3SS,
and the AIM2 inflammasome, which senses cytosolic DNA, were
largely dispensable for IL-1β secretion in EHEC-infected macro-
phages (Fig. S1 E and F). Although recent studies identified an
important role for protein kinase R (PKR), a dsRNA-activated
protein kinase with well-documented antiviral activities, in the
activation of inflammasomes (9), we found no role for PKR in
regulating inflammasome-dependent IL-1β production in re-
sponse to EHEC, nigericin, or poly(dA:dT) (Fig. S1G).
To test the role of known EHEC virulence factors in inflam-
masome activation, we infected macrophages with EHEC strains
deficient in a variety of virulence genes. Consistent with our data
from NLRC4/IPAF-deficient cells, deletion of the EHEC T3SS
only marginally affected IL-1β induction (Fig. 1D). Stx, a major
virulence factor required for EHEC-induced intestinal and renal
disease, did not contribute to IL-1β production (Fig. 1D). EHEC
lacking plasmid pO157, which encodes enterohemolysin, a pore-
forming toxin previously implicated in NLRP3 activation (4),
showed only a marginal defect in IL-1β production (Fig. 1D).
Finally, a panel of EHEC strains lacking different O-islands (OI),
i.e., segments of the EHEC genome that are lacking in the ge-
nome of the laboratory strain E. coli K12 that often encode pu-
tative or documented virulence factors (10), induced IL-1β that is
comparable to wild-type EHEC-induced IL-1β (Fig. 1D). Notably,
IL-1β responses elicited by pO157- and stx-deficient mutants
were still entirely NLRP3 dependent (Fig. 1E), indicating the
existence of a predominant, presumably virulence-independent,
mechanism by which EHEC activates the NLRP3 inflammasome.
Consistent with this idea, avirulent strains of E. coli such as K12,
BL21, as well as different “pathotypes” such as enterotoxigenic
E. coli (ETEC) harboring virulence genes distinct from those of
EHEC also elicited IL-1β production in an NLRP3-dependent
fashion (Fig. 1F). Heat-killing the bacteria, or blocking bacterial
phagocytosis or lysosomal acidification using cytochalasin D and
bafilomycin A, respectively, inhibited EHEC-induced IL-1β se-
cretion (Fig. 1 G−I), suggesting that phagocytosis of viable
bacteria followed by their degradation within the lysosomal com-
partment is an important event upstream of NLRP3 activation.
EHEC RNA Accesses the Cytosol and Activates the NLRP3 Inflammasome.
As EHEC activates the NLRP3 inflammasome, a molecular plat-
form localized in the cytosolic compartment, we asked whether,
following phagocytosis and lysosomal killing, EHEC components
such as nucleic acids translocate from the lysosomes to an in-
tracellular location to trigger inflammasome activation. Bacterial
mRNA has been shown to induce NLRP3 inflammasome acti-
vation and IL-1 responses (7, 8). However, it is not clear if bac-
terial nucleic acids, including mRNA, are released from the
lysosome into the cytosol following bacterial killing and deg-
radation. To determine whether EHEC RNA is released into
the cytosol of BMDMs during infection, we performed subcellular
fractionation of infected and uninfected cells (11). The purity of
the cytosolic fraction was verified by the lack of LAMP1, a lyso-
somal marker (Fig. 2A). RNA from cytosolic or organellar (in-
cluding lysosomal) fractions was subjected to quantitative real-
time PCR to measure EHEC representatives of ribosomal (rrs
encoding16s rRNA) or messenger (eae, encoding intimin) RNA.
As predicted, cytosolic and lysosomal fractions of uninfected
cells did not contain EHEC RNA, whereas lysosomal fractions of
infected cells contained both transcripts (Fig. 2 B and C). Re-
markably, rrs and eae RNA of EHEC were also detected in the
cytosolic fraction of infected macrophages, suggesting that a
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Fig. 1. EHEC activates NLRP3 inflammasome independent of its major virulence
factors. (A−G) IL-1β in supernatants of BMDMs from indicated genotypes infected
with EHEC or various E. coli strains or heat-killed EHEC (HK EHEC) at a multiplicity
of infection (MOI) of 25 for 8 h or treated with poly(dA:dT) for 6 h or nigericin for
1 h. (H and I) IL-1β in the supernatants of C57BL/6 BMDMs treated with cyto-
chalasin D (CytD; 2 μM), DMSO, or bafilomycin A (50−150 nM) or left untreated
for 30min or 1 h before infectingwith EHEC (MOI = 25) for 8 h. Data presented as
mean SEM are from one experiment representative 2–3 experiments.
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significant fraction of bacterial RNA is translocated to the cy-
tosol following phagocytosis (Fig. 2 B and C).
To attempt to visualize the cytosolic bacterial RNA, we la-
beled live EHEC with a clickIT RNA labeling system, which
labels newly synthesized RNA, and analyzed the cells by confocal
microscopy at various time points following infection. EHEC
were phagocytosed within 30 min of infection (Fig. S2A) and, by 2 h
postinfection EHEC RNA (Fig. 2D and Fig. S2A) began to trans-
locate to the cytosol from the lysosomes. Consistent with the large
fraction of the rrs and eae transcripts found in the cytosol by frac-
tionation, ∼20–25% of cells displayed one or more foci of bacterial
RNA in the cytosol by 2 h of infection. These foci of RNA were not
associated with bacteria, and, in fact, intact bacteria were not found
in the cytosol, consistent with the fact that EHEC is an extracellular
bacterium excluded from the cytosolic compartment by the bacte-
ricidal activity of the phagosomal machinery. We also observed
specks of EHEC DNA in the cytosol of infected BMDMs (Fig.
S2B), but, as mentioned above, the DNA sensor AIM2 was not
required for EHEC-induced IL-1β production. Consistent
with the hypothesis that lysosomal acidification is required for
this translocation, bafilomycin A inhibited detectable release of
nucleic acids into the macrophage cytosol following phago-
cytosis of live bacteria (Fig. S2C).
Notably, EHEC RNA released into the cytosol colocalized with
NLRP3 specks (Fig. 2E), which are indicative of the assembly of the
macromolecular NLRP3 inflammasome complex (12). Furthermore,
transfection of macrophages with purified EHEC RNA potently
activated IL-1β production in an NLRP3-dependent manner (Fig.
2F), and transfection with RNase A protein [but not a control
protein R-phycoerythrin (R-PE)] into the cytosol before EHEC in-
fection resulted in a marked reduction in IL-1β production, but not
TNF-α, consistent with a role for cytosolic EHEC RNA in NLRP3
activation by EHEC (Fig. 2G). Thus, EHEC RNA has a significant
role in EHEC-induced inflammasome activation. Interestingly,
although colocalization of EHEC RNA and NLRP3 was frequent
(25% of cells), we also observed NLRP3 specks in ∼20% of
EHEC-infected cells that were not colocalized with EHEC RNA
(Fig. S2D), indicating the presence of an additional bacterial
stimulus that likely elicits NLRP3 complex formation in cells.
Bacterial RNA:DNA Hybrids Access the Cytosol and Colocalize with the
NLRP3 Inflammasome. In addition to RNA and DNA species,
prokaryotic cells possess RNA:DNA hybrids, which are generated
during DNA replication and transcription (13, 14). RNA:DNA
hybrid molecules are a relatively stable and abundant species of
nucleic acids in prokaryotes. The presence of both bacterial
RNA and DNA in the cytosol raised the possibility that EHEC
RNA:DNA hybrids might be released into the cytoplasm from
killed phagosomal bacteria to trigger an innate immune response.
Using a well-characterized monoclonal antibody that specifically
detects RNA:DNA hybrids (15), we detected RNA:DNA hybrids
in the nucleus of almost all infected and uninfected cells, con-
sistent with their generation and accumulation during normal
eukaryotic DNA replication and transcription (Fig. 3A and Fig.
S3A). In addition to eukaryotic hybrids in the nucleus, RNA:DNA
hybrids were observed within the phagosomes of infected but not
of uninfected cells (Fig. S3B). Notably, starting 1 h after infec-
tion, we detected bacterial RNA:DNA hybrids in the cytosol
of infected macrophages (Fig. 3A). Importantly, both the anti-
RNA:DNA hybrid antibody and the clickIT system, which stains
newly synthesized bacterial RNA and thus the RNA in RNA:DNA
hybrids formed during transcription, detected the same hybrid
specks in the cytosol, indicating that these hybrids are in fact of
bacterial, not eukaryotic, origin (Fig. 3B).
To determine if bacterial RNA:DNA hybrids, like bacterial
RNA species, colocalized with inflammasomes in the cytosol, we
costained cells for hybrids, NLRP3, ASC, and caspase-1 (Fig. 3C
and Fig. S4A). At 2 h of infection, ∼40% of the cells contained
RNA:DNA hybrid specks in the cytosol and, notably, 75% of
these RNA:DNA hybrid specks colocalized with NLRP3 and
caspase-1, implicating RNA:DNA hybrids as important inflam-
masome activators in EHEC infection (Fig. 3D and Fig. S4B).
Approximately 10% of the cells contained NLRP3-caspase-1
specks that did not colocalize with RNA:DNA hybrids. Given
our finding that EHEC RNA is found in the cytoplasm, these
hybrid-negative specks could be NLRP3 inflammasomes trig-
gered by EHEC RNA.
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To test whether RNA:DNA hybrids are required for the activa-
tion of NLRP3 during EHEC infection, we delivered into the
macrophage cytosol RNase H, which specifically degrades the RNA
in the RNA:DNA hybrid molecules (14, 16). This treatment abro-
gated IL-1β production in response to EHEC. The inhibitory effect
of RNase H was specific for EHEC infection, because IL-1β pro-
duction induced by the AIM2 ligand poly(dA:dT) or the NLRP3
activator nigericin was unaffected (Fig. 3E). Furthermore,
RNase H did not affect the production of an inflammasome-
independent cytokine, TNF-α, by EHEC (Fig. S4C), demonstrat-
ing that its inhibitory effect was specific for EHEC-induced IL-1β.
Synthetic RNA:DNA Hybrids Activate the NLRP3 Inflammasome. To
further determine if RNA:DNA hybrids are capable of activating
NLRP3 inflammasome in the absence of other bacterial com-
ponents, we tested whether a 120-bp synthetic RNA:DNA hybrid
homologous to a portion of the EHEC rimM gene could activate
NLRP3 inflammasome in macrophages. The purity of the syn-
thetic hybrid preparation was verified by agarose gel electro-
phoresis (Fig. S5A). Similar to a recent study by Rigby et al. (17),
we observed that the synthetic RNA:DNA hybrids induced IFN
(IFN)-β production, albeit at modest levels (Fig. S5B). Notably,
RNA:DNA hybrids potently stimulated the activation of caspase-1
and production of IL-1β and IL-18 (Fig. 4 A–C). As predicted,
AIM2 was dispensable for inflammasome activation by RNA:DNA
hybrids (Fig. S5C). In contrast, all of these inflammasome-mediated
responses triggered by synthetic bacterial RNA:DNA hybrids were
NLRP3 dependent (Fig. 4 A and B).
RNase H Deficiency in Bacteria Enhances Inflammasome Activation.
To directly test if bacterial RNA:DNA hybrids contribute to
NLRP3 activation during infection, we used an E. coli strain de-
ficient in RNase H enzyme (E. coli ΔrnhA), which specifically
degrades RNA:DNA hybrids by degrading the RNA primer dur-
ing DNA replication (14, 16). E. coli ΔrnhA strain accumulates
higher levels of long and stable RNA:DNA hybrids (16, 18) but
has growth kinetics and total RNA levels comparable to wild-type
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(WT) E. coli (Fig. S6 A and B). In addition, the rnhA mutant was
killed within macrophages at a rate indistinguishable from WT
(Fig. S6C). Supporting our hypothesis, the overproduction of
RNA:DNA hybrids by E. coli resulted in enhanced NLRP3 acti-
vation as infection of macrophages with E. coli ΔrnhA resulted in
a marked increase in the production of IL-1β and IL-18 as well as
cleavage of caspase-1 and IL-1β relative to its parent strain (Fig.
5 A–C). This enhanced macrophage response was specific for
NLRP3 activation, because E. coli ΔrnhA induce inflammasome-
independent cytokines such as TNF and IL-6 at levels similar to
WT (Fig. S6 D and E). The elevated IL-1β response elicited by
ΔrnhA E. coli was completely dependent on ASC and NLRP3
(Fig. 5D). Importantly, complementation of E. coli ΔrnhA with
plasmid-encoded RNase H (“prnhA”) attenuated the increase in
caspase-1 and IL-1β processing and the secretion of IL-1β and
IL-18 to WT levels (Fig. 5 A–C). Although the number of hybrid
specks visualized after infection with E. coli ΔrnhA was not sig-
nificantly higher than upon infection by WT E. coli (Fig. S6F),
delivery of RNase H enzyme into ΔrnhA-infected reduced IL-1β
production to levels equivalent to those of WT-infected mac-
rophages, verifying that the enhanced inflammasome response
induced by ΔrnhA E. coli was in fact due to higher levels of
RNA:DNA hybrids (Fig. 5E). E. coli ΔrnhA appeared to induce
greater than WT levels of oligomeric forms of ASC in an ASC
oligomerization assay, raising the possibility that increased levels
of RNA:DNA hybrids in the mutant may lead to increased in-
flammasome assembly (Fig. S6G). The recognition of RNA:DNA
duplexes was not exclusive to macrophages; upon infection of
dendritic cells, E. coli ΔrnhA induced greater inflammasome
activation, characterized by IL-1β and IL-18 secretion and caspase-1
and IL-1β maturation (Fig. 5 F–H). As above, genetic comple-
mentation of E. coli ΔrnhA restored caspase-1 activation, IL-1β
maturation, and IL-1β as well as IL-18 secretion to WT levels
(Fig. 5 F–H). Overall, the bacterial genetic complementation and
cytosolic RNase H delivery approaches provide direct evidence
for RNA:DNA hybrids being bona fide bacterial components
contributing to NLRP3 inflammasome activation during bacterial
infection.
Discussion
IL-1β is a potent inflammatory cytokine implicated in the out-
come of EHEC disease (19). The production of bioactive IL-1β is
regulated by cytosolic inflammasome complexes (6). In this
study, we report that EHEC-induced IL-1β maturation and
production occurred independently of known virulence factors;
rather, induction of IL-1β secretion required uptake of EHEC
and acidification of phagosomes, implicating EHEC breakdown
products such as nucleic acids in this process.
Microbial nucleic acids have long been known to trigger host
responses. Bacterial and viral RNA and DNA are potent acti-
vators of type I IFNs and IL-1 cytokines. Bacterial mRNA has
been shown to induce NLRP3 inflammasome activation and IL-1
responses (7, 8). Using both microscopic and biochemical ap-
proaches, we have shown here that EHEC RNA was delivered
into the host cell cytosol, colocalized with NLRP3 foci and
triggered inflammasome activation in an NLRP3-dependent
manner. Cytosolic delivery of exogenous RNase A attenuated the
EHEC-driven IL-1β response.
Another class of nucleic acid species abundant in bacteria are
RNA:DNA hybrids, which are formed during bacterial DNA
replication and transcription (13, 14). During bacterial DNA
synthesis, short RNA strands serve as primers for both leading and
lagging strand (Okazaki fragments) synthesis, and RNA:DNA
hybrids are formed every 100–200 nucleotides during lagging
strand synthesis (20, 21). RNA:DNA hybrids are also formed
during transcription, when a newly formed mRNA transcript is
paired with one strand of duplex DNA (13). Notably, RNA:DNA
hybrids have a relatively stable structure and withstand acidic
conditions up to pH 5.5 (22, 23). Several lines of evidence in this
study indicated that RNA:DNA hybrids of bacterial origin play
a key role in NLRP3 inflammasome activation by EHEC. First,
EHEC RNA:DNA hybrids were released into the cytosol of
infected cells and colocalized with NLRP3 inflammasome. Sec-
ond, depletion of EHEC RNA:DNA hybrids in the infected cells
by the cytosolic delivery of RNase H enzyme specifically inhibited
NLRP3 activation by EHEC. Third, an E. coli strain harboring
higher levels RNA:DNA hybrids due to the lack of RNase H in-
duced NLRP3 activation more efficiently than WT bacteria. The
findings of this study thus collectively identify bacterial RNA:DNA
hybrids as a unique microbe-associated molecular pattern triggering
NLRP3 inflammasome activation. Interestingly, RNA:DNA hybrids
have been recently shown to induce type I IFNs in a TLR9-MyD88-
dependent manner (17).
Collectively, our findings highlight an emerging theme in host−
pathogen interactions that the cytosolic immune surveillance
mechanism is central to sensing extracellular or vacuolar bacteria
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Fig. 5. RNase H deficiency in bacteria enhances inflammasome activation.
(A, B, F, and G) IL-1β and IL-18 in the supernatants of C57BL/6 BMDMs (A and
B) or BMDCs (F and G) infected with indicated strains of E. coli at MOI = 25
for 8 h. (C and H) Immunoblots for cleaved caspase-1 and IL-1β in the
supernatants or NLRP3, proIL-1β p31 and GAPDH in the lysates of C57BL/6
BMDMs (C) or BMDCs (H) infected with indicated E. coli strains for 8 h. (D) IL-
1β in the supernatants of BMDMs indicated genotypes infected with in-
dicated E. coli strains for 8 h. (E) IL-1β in the supernatants of BMDMs pre-
treated with RNase H for 2 h or left untreated before infecting with
indicated E. coli strains for 8 h. Asterisk (*) indicates P < 0.05 for WT vs.
ΔrnhA or WT vs. ΔrnhA/prnhA as determined by one-way ANOVA followed
by Bonferroni test. Data presented as mean SEM are from one experiment
representative 2–3 experiments.
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through detection of microbial products that access the cytosol from
phagosomes. Although EHEC is excluded from the cytosol owing
to its susceptibility to the microbicidal nature of phagolysosomes,
cytosolic sensing of EHEC is yet an integral part of innate im-
mune responses to EHEC. The inflammasome-dependent cyto-
solic surveillance of EHEC relies heavily on the detection of
bacterial nucleic acids in the cytosol rather than on virulence
factors. Considering that nonpathogenic laboratory strains of
E. coli, as well as other pathogenic strains of E. coli such as ETEC,
stimulated NLRP3 inflammasome activation, the recognition of
nucleic acids such as RNA or RNA:DNA hybrids may be a
general mechanism by which the cytosolic innate immune system
recognizes E. coli irrespective of virulence factor armament and
pathogenic potential (8).
NLR inflammasomes such as NLRP1b and NLRC4/IPAF are
activated by specific interaction with ligands such as anthrax
toxin and bacterial T3SS/flagellin, respectively (6). In contrast,
NLRP3 activation is triggered by a plethora of stimuli of diverse
nature such as bacterial mRNA, pore forming toxins, crystalline
particles, and cellular perturbations such as ionic imbalance. The
prevailing consensus is that these disparate stimuli converge on
one or more common elements or events upstream of NLRP3
(6). Although bacterial RNA has been shown to activate the
NLRP3 inflammasome, the mechanism by which this occurs is
not yet known. PKR represented an attractive candidate re-
sponsible for RNA-mediated inflammasome activation, but in
contrast to published work (9), we found that PKR-deficient cells
were not compromised for EHEC-induced NLRP3 inflamma-
some signaling. Similar observations were reported by Nuñez
and colleagues (24). Interestingly, a recent study (25) demon-
strated that DHX33, a DExD/H-box RNA helicase family member,
is a sensor for viral dsRNA and it activates inflammasome by
directly binding to NLRP3. It is possible therefore that either
DHX33 or a similar cytosolic sensor(s) for RNA and RNA:DNA
hybrids activates NLRP3 in EHEC infection, or that NLRP3 may
sense these bacterial nucleic acids directly.
Our identification of bacterial RNA:DNA hybrids as activa-
tors of innate immunity has broad implications for microbial
recognition and host immunity. RNA:DNA hybrids are also
formed as replication intermediates in the life cycle of retro-
viruses (26), and it is possible that such hybrids generated during
active retroviral replication also contribute to NLRP3 inflam-
masome-mediated immune responses. As with other nucleic acid
sensing mechanisms, the ability of the innate immune system to
detect RNA:DNA hybrids may also contribute to autoimmune
disease. Eukaryotic cells generate RNA:DNA hybrids during
transcription, genomic replication, mitochondrial DNA replica-
tion, and Ig class switching in B cells (13). Cytosolic exclusion of
RNA:DNA hybrids, like that of self-DNA, by nuclear and mi-
tochondrial compartmentalization could be a regulatory mech-
anism responsible for preventing self-RNA:DNA hybrids from
activating cell-intrinsic innate immune responses. Degradation of
self-RNA:DNA by RNase H in the nucleus may provide an ad-
ditional mechanism to avoid recognition of this product. Indeed,
Aicardi Goutieres syndrome (AGS), a hereditary neurodegen-
erative disorder characterized by autoimmune activation and type
I IFN production, has been associated with mutations in the hu-
man RNASEH2B, which encodes an important subunit of the
RNase H enzyme (27). Although the role of NLRP3 activation
in AGS remains undefined, the identification of RNA:DNA
hybrids as triggers of innate immunity provides new insights
into cytosolic immune surveillance mechanisms with potentially
important implications for host defense and autoimmunity.
Materials and Methods
A detailed materials and methods is given in SI Materials and Methods.
Briefly, BMDMs and BMDCs were generated fromWT and knockout mice and
were stimulated with bacteria (Table S1) or other activators as described before
(28). Inflammasome responses were analyzed by ELISA and immunoblotting for
IL-1β and caspase-1 or confocal microscopy as described before (28, 29).
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